(Seoul=NSP News Agency) jeong seop park Journalist = Rezolute, a leading US new drug developer,a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, announced that Nevan Charles Elam, CEO and Founder, will present at two upcoming virtual investment conferences.

•H.C. Wainwright 23rd Annual Global Investment Conference - Monday, September 13, 2021, on demand beginning at 7:00 a.m. ET, corporate presentation
•Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Tuesday, September 21, 2021 at 2:55 p.m. ET,

Handok, a South Korean pharmaceutical company, has a 24.13% stake in Rezolute. Handok is listed on the Korean stock market.